Newsletter

000100 - Yuhan Corporation

000100 Summary

Biopharma

Stock Price & Overview

₩79,100 -1,600 (-1.98%) Close · Sep 8, 2026 KST

KOSPI | ₩KRW | Close: ₩79,100 ≈ US$57 · Market cap ₩5.8tn (≈ $4.2bn)

Home › 000100 › Filings

Investor Relations Event

DART

Yuhan Corporation

Filed Sep 8, 2026 KST · IR · receipt 20260908800264

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.

Korean form name: 기업설명회(IR)개최(안내공시)

000100

Price: ₩79,100
Change: -1.98%
Market cap: ₩5.8tn
Prev. close: ₩80,700

000100 Summary Compare to Peers

000100 data on kstock

Financials: 11 fiscal years
Valuation: Daily P/E, P/S, P/B, P/CF
Earnings: Eight quarters
Dividends: Per-share history

Every figure is taken from Yuhan Corporation's own DART filings and matched on IFRS account codes, so a line holds across years where the Korean wording changed.

kstock analysis on 000100

Yuhan: The $95m Order Comes From The Half Nobody Buys The Stock For

Sep 2, 1:26 AM

All 000100 analysis

More 000100 filings

000100 - Yuhan Corporation

Investor Relations Event

000100

000100 data on kstock

kstock analysis on 000100

Yuhan: The $95m Order Comes From The Half Nobody Buys The Stock For

More 000100 filings

Yuhan signs $95m API supply deal with an undisclosed global drugmaker

Serious industrial accident (subsidiary)

Fair-trade compliance programme status (notice)

Investor Relations Event

Half-Year Report

5% Ownership Report — Short Form